US BANCORP \DE\ - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 1 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2020$0
-100.0%
200
-41.3%
0.00%
Q3 2020$1,0000.0%341
+141.8%
0.00%
Q2 2020$1,000
-88.9%
141
-90.6%
0.00%
Q1 2018$9,000
+50.0%
1,500
+87.5%
0.00%
Q4 2017$6,0000.0%8000.0%0.00%
Q3 2017$6,000
+20.0%
8000.0%0.00%
Q2 2017$5,000
-28.6%
8000.0%0.00%
Q1 2017$7,0008000.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q3 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$27,550,00020.34%
AdvisorShares Investments LLC 380,750$2,079,0001.29%
ETF MANAGERS GROUP, LLC 5,779,642$31,557,0001.10%
DAFNA Capital Management LLC 297,300$1,623,0000.56%
GENERAL AMERICAN INVESTORS CO INC 632,400$3,453,0000.32%
Aries Wealth Management 27,900$160,0000.10%
Virtus ETF Advisers LLC 81,751$446,0000.07%
Omnia Family Wealth, LLC 21,726$119,0000.06%
HighVista Strategies LLC 12,200$67,0000.05%
WOODSTOCK CORP 57,213$312,0000.05%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders